TrialThe Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease
Trial details
- Registry ID
- NCT05759208
- Phase
- Phase 2
OKYO
Okyo Pharma Ltd
Company identity checked against sources
Browse linked trials and recorded changes, or follow this company for updates.
3Trials in this database
0Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far
Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.
Completion dates · Pro
Which trial dates moved later?
Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features
Included trials
Check company identity source| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye DiseaseNCT05759208 | OKYO | Phase 2 | Completed | 2023-12-15Actual |
| The Study Assessing the Safety and Efficacy of OK-101 Treatment in Subjects With Neuropathic Corneal PainNCT06637527 | OKYO | Phase 2 | Terminated | 2025-04-30Actual |
| Phase 3, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Study Assessing the Safety and Efficacy of Urcosimod Ophthalmic Solution in Participants With Neuropathic Corneal Pain (NCP).NCT07838506 | OKYO | Phase 3 | Not yet recruiting | 2027-05Estimated |
The Study Assessing the Safety and Efficacy of OK-101 Treatment in Subjects With Neuropathic Corneal Pain
Trial details
- Registry ID
- NCT06637527
- Phase
- Phase 2
Phase 3, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Study Assessing the Safety and Efficacy of Urcosimod Ophthalmic Solution in Participants With Neuropathic Corneal Pain (NCP).
Trial details
- Registry ID
- NCT07838506
- Phase
- Phase 3
Latest recorded trial changes
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.